Phosphatidylcholine 2,400mg for 12 Weeks Drops NAFLD Grade S3 from 84.6% to 51.3%. PEMT Variant in 40% of Women Decides Dietary Dependence
WELLNESS

Phosphatidylcholine 2,400mg for 12 Weeks Drops NAFLD Grade S3 from 84.6% to 51.3%. PEMT Variant in 40% of Women Decides Dietary Dependence

By Olivia · · Therapeutic Advances 2025 · Phosphatidylcholine NAFLD RCT 12-Week
KO | EN

Phosphatidylcholine (PC) supplementation in non-alcoholic fatty liver disease (NAFLD) is settling as a meaningful clinical option. The Therapeutic Advances 2025 RCT reported that 39 NAFLD patients on phosphatidylcholine 2,400mg/day for 12 weeks dropped grade S3 fatty liver proportion from 84.6% to 51.3%. Meanwhile liver enzymes (ALT·AST), leptin, and TBARS (oxidative stress marker) all decreased meaningfully.

The bigger clinical meaning for women is the PEMT gene variant. About 40% of women carry a PEMT gene variant that partially reduces self-choline synthesis. Estrogen normally stimulates PEMT expression, but with the variant this backup circuit is weak. The Chinese 56,000-cohort study showed women with highest choline intake had 32% lower NAFLD risk versus lowest.

What Is Phosphatidylcholine

Phosphatidylcholine (PC) is a type of phospholipid and a core component of cell membranes. Choline + glycerol + two fatty acids + phosphate group. PC makes up 50%+ of all human cell membranes. Core component of hepatocyte membrane.

Dietary sources:

  • Egg yolk: PC ~200mg + choline 147mg per egg
  • Soy (lecithin): extracted from soybeans, primary supplement form
  • Liver: richest source (beef·chicken liver 600mg+ PC per 100g)
  • Fish: cod·salmon 200mg PC per 100g
  • Dairy: moderate amounts in milk·cheese
  • Nuts: walnuts·cashews

PEMT Gene Variant

PEMT gene (phosphatidylethanolamine N-methyltransferase) encodes the enzyme that converts phosphatidylethanolamine to PC in the liver. When this enzyme works normally, the body can synthesize PC even with insufficient dietary choline.

Problem: about 40% of women carry the PEMT variant (rs7946). With the variant:

  • PEMT activity reduced 30~50%
  • Self PC synthesis partially impaired
  • Increased dietary choline dependence
  • NAFLD risk increase
  • Risk accelerates further post-menopause (loss of estrogen’s PEMT stimulation)

Clinical Data

Therapeutic Advances 2025 (n=39 RCT):

  • PC 2,400mg/day for 12 weeks vs conventional management
  • Fatty liver grade S3: 84.6% → 51.3% (-39% relative reduction)
  • ALT·AST: meaningful reduction
  • Leptin: reduction (adipocyte hormone, NAFLD progression marker)
  • TBARS: reduction (oxidative stress marker)
  • CAP score: improvement (liver fat quantification score)
  • Liver fibrosis: partial improvement

Chinese 56,000-Person Cohort

Inverse correlation between dietary choline intake and NAFLD risk:

  • Highest vs lowest choline intake quartile
  • Women: 32% NAFLD risk reduction
  • Men: 14% NAFLD risk reduction (less strong)
  • PEMT variant women: greater choline dietary dependence

NAFLD Molecular Circuit

NAFLD progression circuit:

  1. Fatty acid influx ↑ (diet + adipose tissue lipolysis)
  2. Hepatic fatty acid synthesis ↑ (insulin resistance + high-carb diet)
  3. Fatty acid → triglyceride → VLDL secretion
  4. PC deficiency: VLDL secretion not normal → liver fat accumulation
  5. Chronic inflammation + oxidative stress: NASH progression
  6. Liver fibrosis → cirrhosis

PC’s core circuit: normalizes VLDL secretion → exports liver fat. PC deficiency is one molecular core of NAFLD.

Dose Recommendations

  • NAFLD diagnosis: PC 2,400mg/day for 12+ weeks (clinical RCT dose)
  • NAFLD risk + PEMT variant: PC 1,000~2,000mg/day
  • Post-menopause + risk factors: PC 500~1,000mg/day + dietary choline emphasis
  • Pregnancy (liver protection + fetal brain development): choline 450~550mg/day (diet + supplement)

With food. Effect from 4–8 weeks, 12+ week cumulative evaluation.

Diet-First Approach

Strengthen dietary choline before PC supplementation:

  • Eggs 1~2/day (yolk is central)
  • Liver 1–2×/week (beef·chicken liver 100g)
  • Fish 2–3×/week (cod·salmon·sardines)
  • Soy foods (tofu, soy milk, cheonggukjang)
  • Handful of nuts daily

400~600mg daily choline reachable through diet. But PEMT variant + NAFLD-diagnosed patients reasonable for supplement addition.

Side Effects

Generally well tolerated:

  • GI discomfort: nausea, diarrhea in some
  • Fishy odor: TMA from choline metabolism in some patients. Avoidable with batch-choline supplements
  • TMAO concern: gut bacteria convert choline to TMA, oxidized to TMAO in liver → some cardiovascular risk data. Strong evidence that dietary choline directly raises TMAO risk is lacking
  • Pregnancy-suitable: safety confirmed, supports fetal brain development

Matrix Application

PC alone is weak for NAFLD recovery. Matrix essential:

  • Weight loss 7–10%: central to NAFLD recovery
  • Diet (Mediterranean·low-sugar): insulin resistance circuit
  • Exercise 150 min/week: hepatic fatty acid oxidation
  • Alcohol avoidance
  • Metformin·inositol·ALA: insulin circuit (with PCOS)
  • Omega-3 1,000~2,000mg: chronic inflammation attenuation
  • Vitamin E 800 IU (NASH-diagnosed patients)
  • PC 2,400mg (PEMT variant + diagnosis)

Korean Market

Korean MFDS-recognized functional areas:

  • Choline: cognitive·memory support (some forms)
  • PC: little direct functional approval, sold as general food or lecithin form

Not labeled with NAFLD indication. Physician prescription or self-supplementation area.

Conclusion

For women with NAFLD, PC supplementation is a clinically justified option. Especially meaningful for the 40% with PEMT gene variant, post-menopausal NAFLD acceleration patients, and dietary choline-deficient patients. Drugs (GLP-1, metformin) + lifestyle (weight loss, exercise, diet) matrix is priority and PC is supportive. Not a standalone answer but one tool of the matrix.

Source: Therapeutic Advances 2025 · Phosphatidylcholine NAFLD RCT 12-Week